Advertisement

Osteoporosis International

, Volume 1, Issue 4, pp 215–217 | Cite as

How can we tell if a treatment works? Further thoughts on the randomized controlled trial

  • R. P. Heaney
Guest Editorial

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rose GA. The study of osteoporosis and osteomalacia. Postgrad Med J 1964; 40:158–63.CrossRefPubMedGoogle Scholar
  2. 2.
    Mosekilde L. Age-related changes in vertebral trabecular bone architecture-assessed by a new method. Bone 1988; 9:247–50.CrossRefPubMedGoogle Scholar
  3. 3.
    Rich C, Bernstein DS, Gates S et al. Factors involved in an objective study of the efficacy of treatment of osteoporosis. Clin Orthop 1966; 45:63–6.PubMedGoogle Scholar
  4. 4.
    Riggs BL, Hodgson SF, O’Fallon WM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990; 322:802–9.PubMedGoogle Scholar
  5. 5.
    Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH. Effect of intermittent, cycLJcal etidronate therapy on bone mass and fracture rate in postmenopausal osteoporosis. N Engl J Med 1990; 322:1265–71.PubMedGoogle Scholar
  6. 6.
    Watts NB, Harris ST, Genant HK et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990; 323:73–9.PubMedGoogle Scholar
  7. 7.
    Wolf S. The pharmacology of placebos. Pharmacol Rev 1959; 11:689–704.PubMedGoogle Scholar
  8. 8.
    Beecher HK. The powerful placebo. JAMA 1955; 159:1602–6.Google Scholar
  9. 9.
    Goodwin JS, Goodwin JM, Vogel AV. Knowledge and use o placebos by house officers and nurses. Ann Intern Med 1979; 91:106–10.PubMedGoogle Scholar
  10. 10.
    Heaney RP. How do we know what we know? The randomized controlled trial revisited. J Bone Miner Res 1991; 6:103–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Feinstein AR. Epidemiologic analyses of causation: the unlearned scientific lessons of randomized trials. J Clin Epidemiol 1989; 42:481–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Korn EL, Baumrind S. Randomized cLJnical trials with clinician-preferred treatment. Lancet 1991; 337:149–52.CrossRefPubMedGoogle Scholar
  13. 13.
    Veatch RM. Justice and research design: the case for a semirandomization clinical trial. Clin Res 1983; 31:12–22.PubMedGoogle Scholar

Copyright information

© European Foundation for Osteoporosis 1991

Authors and Affiliations

  • R. P. Heaney
    • 1
  1. 1.Creighton UniversityOmahaUSA

Personalised recommendations